Abstract: A composition for local anesthesia which comprises (A) lidocaine, (B) a catecholamine such as epinephrine in an amount of, for example, 1/200,000 (g/ml) based on the volume of the composition, and (C) one or more amino acids such as glycine, glutamic acid, and L-glutamic acid-L-lysine or one or more hydroxycarboxylic acids such as lactic acid, glycolic acid, and citric acid, which has a duration suitable for short-time dental operations such as tooth extraction and excellent storage stability.

Abstract: An aqueous pharmaceutical composition comprising sodium cromoglicate as an active ingredient and a quaternary ammonium compound such as benzalkonium chloride as a preservative, characterized in that said composition comprises a precipitation inhibitor selected from the group consisting of alkanolamines including 2-aminoethanol and tocopherols including d-.alpha.-tocopherol is provided. The composition has characteristic feature of free from precipitation or turbidity in manufacturing processes and during storage.

Abstract: The present invention relates to a pharmaceutical composition in a form of a film. The composition comprises (a) a butyrophenone compound and (b) a vehicle comprising polyvinyl acetal diethylaminoacetate and polyvinyl pyrrolidone. The ratio of the compound to the vehicle is from 1% to 80% by weight based on the total weight of the vehicle and the ratio by weight of polyvinyl acetal diethylaminoacetate and polyvinyl pyrrolidone is from 1:9 to 9:1. The pharmaceutical composition can be applied to the skin of a patient for a long time and maintain a therapeutically effective blood level of the butyrophenone.